AlphaCrest Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
AlphaCrest Capital Management's LLY Position: Q4 2022 in Review
AlphaCrest Capital Management sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 1,434 shares — an estimated $464K sold.
AlphaCrest Capital Management first reported a position in LLY in Q4 2018 and held it in 16 quarters. The position peaked at $10.9M in Q1 2021. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- AlphaCrest Capital Management reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
- AlphaCrest Capital Management sold 1,434 Eli Lilly shares in Q4 2022, an estimated $464K.
- AlphaCrest Capital Management first reported a position in Eli Lilly in Q4 2018 and held it in 16 quarters.
- AlphaCrest Capital Management's Eli Lilly position peaked at $10.9M in Q1 2021.
- 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on AlphaCrest Capital Management's 13F filing for Q4 2022.